secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acrivon Therapeutics, Inc. (ACRV)
CIK:        0001781174
Form:       8-K
Filed at:   2026-06-17T21:28:03+00:00
Accession:  0001193125-26-274410
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acrivon stockholders OK 3M share equity plan increase; elect Tomsicek, Baum
---------------------------------------------------------------------------

- Share reserve increased by 3M shares to 8,606,723; annual 5% auto-increase through 2032 approved.
- Michael Tomsicek and Charles Baum elected Class I directors until 2029 annual meeting.
- PricewaterhouseCoopers ratified as independent auditor for fiscal year 2026.
- Proposals passed with >65% of votes cast; quorum 73.21% of outstanding shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1781174/000119312526274410/0001193125-26-274410-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1781174/000119312526274410/acrv-20260617.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-274410

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer